Fol. Biol. 2002, 48, 96-101
https://doi.org/10.14712/fb2002048030096
Characterization of Functional Domains of Human Interferon Gamma by Specific Monoclonal Antibodies
References
1. 2001) Role of the C-terminal chain in human interferon gamma stability: an electrostatic study. Proteins 43, 125-133.
< , G., Nacheva, G., Todorova, K., Ivanov, I., Karshikoff, A. (https://doi.org/10.1002/1097-0134(20010501)43:2<125::AID-PROT1024>3.0.CO;2-J>
2. 1989) Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects. Experientia 45, 535-541.
< , J. M., Ozaki, Y., Byme, G. I., Brown, R. R., Borden, E. C. (https://doi.org/10.1007/BF01990503>
3. 1992) Inhibition of the biological activity of human interferon-gamma by antipeptide antibodies. J. Interferon Res. 12, 49-54.
< , A., Viani, E., Tiberio, L., Pollara, P., Monti, E., Bonfanti, C., Gao, J., Landolfo, S., Balsari, A., Turano, A. (https://doi.org/10.1089/jir.1992.12.49>
4. 1994) A new, simple, bioassay for human IFN-gamma. J. Immunol. Methods 168, 39-47.
< , W., Wanagat, N., Pilz, K., Seghrouchni, S., Fischer, H. G., Hadding, U. (https://doi.org/10.1016/0022-1759(94)90207-0>
5. 1991) Three-dimensional structure of recombinant human interferon-gamma. Science 252, 698-702.
< , S. E., Cook, W. J., Vijay-Kumar, S., Carson, M., Negabheshan, T. L., Trotta, P. P., Bugg, C. E. (https://doi.org/10.1126/science.1902591>
6. 1993) The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 11, 571-611.
< , M. A., Schreiber, R. D. (https://doi.org/10.1146/annurev.iy.11.040193.003035>
7. 1989) Epitope mapping of recombinant human gamma interferon using monoclonal antibodies. Mol. Immunol. 26, 17-25.
< , C., Wijdenes, J., Cabrillat, H., Djosson, O., Banchereau, J., de Vries, J. E. (https://doi.org/10.1016/0161-5890(89)90015-1>
8. 1986) Objective antiviral assay of the interferons by computer assisted data collection and analysis. Methods domains of human gamma interferon block ligand binding. Enzymol. 119, 533-540.
< , R. L., Schuffman, S. S., Davies, H. A., Mitchell, W. M. (https://doi.org/10.1016/0076-6879(86)19073-2>
9. 1983) A convenient enzyme-linked immunosorbent assay for testing whether monoclonal antibodies recognize the same antigenic site. Application to hybridomas specific for the beta 2-subunit of Escherichia coli tryptophan synthase. J. Immunol. Methods 60, 351-358.
< , B., Ohaniance, L. D., Pages, J., Bussard, A., Goldberg, M. A. (https://doi.org/10.1016/0022-1759(83)90292-2>
10. 1998) Human IFN gamma receptor cytoplasmic domain: expression and interaction with HuIFN gamma. Biochem. Biophys. Res. Commun. 243, 170-176.
< , M. M., Larkin, J. 3rd, Subramaniam, P. S., Szente, B. E., Johnson, N. M. (https://doi.org/10.1006/bbrc.1998.8077>
11. 1989) Amino terminus is essential to the structural integrity of recombinant human interferon-gamma. J. Biol. Chem. 264, 12179-12186.
< , H. H., McPhie, P., Bekisz, J. B., Enterline, J. C., Dyer, D., Webb, D. S., Gerrard, T. L., Zoon, K. C. (https://doi.org/10.1016/S0021-9258(18)63838-4>
12. 1985) Monoclonal antibodies to human interferon-gamma. I. Antibodies to a synthetic carboxyl-terminal peptide. J. Immunol. Methods 80, 55-66.
< , Y., Kurokawa, T., Honda, S., Suzuki, N., Wakimasu, M., Tsukamoto, K. (https://doi.org/10.1016/0022-1759(85)90164-4>
13. 1987) Monoclonal antibodies to human interferon-gamma. II: Antibodies with neutralizing activity. Hybridoma 6, 173-181.
< , Y., Sazuki, N., Kitada, C., Tsukamoto, K. (https://doi.org/10.1089/hyb.1987.6.173>
14. 1982) Neutralization of native human gamma interferon (HuIFN gamma) by antibodies to a synthetic peptide encoded by the 5' end of HuIFN gamma cDNA. J. Immunol. 129, 2357-2379.
< , H. M., Langford, M. P., Lakhchaura, B., Chan, T. S., Stanton, G. J. (https://doi.org/10.4049/jimmunol.129.6.2357>
15. 2001) Differential properties of two putative nuclear localization sequences found in the carboxyl-terminus of human ifn-gamma. J. Interferon Cytokine Res. 21, 341-348.
< , J. 3rd, Subramaniam, P. S., Torres, B. A., Johnson H. M. (https://doi.org/10.1089/107999001750277817>
16. 1985) Antibodies to synthetic polypeptides corresponding to hydrophilic regions of human interferon gamma. Mol. Immunol. 22, 929-936.
< , T., Titmas, R., Parti, S., Meager, A. (https://doi.org/10.1016/0161-5890(85)90079-3>
17. 1989) Functional domains of human interferon gamma probed with antipeptide antibodies. Mol. Immunol. 26, 637-640.
< , S. C., McMullen, G. L, Marzuki, S., Cheetham, B. F. (https://doi.org/10.1016/0161-5890(89)90045-X>
18. 1996) Heparin decreases the blood clearance of interferon-gamma and increases its activity by limiting the processing of its carboxyl-terminal sequence. J. Biol. Chem. 271, 16139-16143.
< , H., Baltzer, F., Grimand, J. A. (https://doi.org/10.1074/jbc.271.27.16139>
19. 1991) The carboxyl-terminal region of human interferon gamma is important for biological activity: mutagenic and NMR analysis. Prot. Eng. 4, 335-341.
< , D., Lunn, C., Dalgarno, D., Fossetta, J., Greenberg, R., Reim, R., Grace, M., Narula, S. (https://doi.org/10.1093/protein/4.3.335>
20. 2001) Evidence for non-enzymatic glycosylation in Escherichia coli. Mol. Microbiol. 39, 1061-1068.
< , R., Niwa, T., Hayashi, H., Dimitrova, R., Ivanov, I. (https://doi.org/10.1046/j.1365-2958.2001.02304.x>
21. 1984) Natural human interferon-gamma. Complete amino acid sequence and determination of sites of glycosylation. J. Biol. Chem. 259, 6790-6797.
< , E., O'Connor, B. H., Rodriguez, H. (https://doi.org/10.1016/S0021-9258(17)39797-1>
22. 1988) Evidence for a polypeptide segment at the carboxyl terminus of recombinant human gamma interferon involved in expression of biological activity. Biochemistry J. 27, 1981-1987.
< , G. F., Wijdenes, J., Nagabhushan, T. L., Trotta, P. P. (https://doi.org/10.1021/bi00406a026>
23. 1994) Synthetic mimics of juxtaposed aminoand carboxyl-terminal peptide domains of human gamma interferon block ligand binding to human gamma interferon receptor. J. Biol. Chem. 269, 358-363.
< , G. F., Prosise, W. W., Taremi, S. S. (https://doi.org/10.1016/S0021-9258(17)42356-8>
24. 1991) Carboxyterminal truncated rhuIFN-gamma with a substitution of Gln133 or Ser132 to leucine leads to higher biological activity than in the wild type. Eur. J. Biochem. 202, 1133-1140.
< , O., Bohm, J., Schone, B., Otto, B. (https://doi.org/10.1111/j.1432-1033.1991.tb16481.x>
25. 1994) The C-terminus of IFN gamma is sufficient for intracellular function. Biochem. Biophys. Res. Commun. 203, 1645-1654.
< , B. E., Soos, J. M., Johnson, H. W. (https://doi.org/10.1006/bbrc.1994.2375>
26. 1991) Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 5, 2516-2522.
< , M. W., Feng, G. (https://doi.org/10.1096/fasebj.5.11.1907934>
27. 1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350-4354.
< , H., Staehelin, T., Gordon, J. (https://doi.org/10.1073/pnas.76.9.4350>
28. Tsanev, R. G., Ivanov, I. (2001) Immune Interferon: Properties and Clinical Application. CRC Press LLC, USA.
29. 1991) The El functional epitope of the human interferon gamma is a nuclear targeting signal-like element. Mapping of the E1 epitope. J. Biol. Chem. 266, 6023-6031.
< , X. W., Jay, F. T. (https://doi.org/10.1016/S0021-9258(18)38076-1>